These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting tumors. Sobel RK US News World Rep; 2000 Oct; 129(13):48-50. PubMed ID: 11183328 [No Abstract] [Full Text] [Related]
3. Colorectal cancer therapeutics and the challenges of applied pharmacogenomics. Kruzelock RP; Short W Curr Probl Cancer; 2007; 31(5):315-66. PubMed ID: 17905192 [No Abstract] [Full Text] [Related]
4. Advances in molecular targets and cancer therapeutics. Westwell AD Drug Discov Today; 2004 Mar; 9(5):207-9. PubMed ID: 14980538 [No Abstract] [Full Text] [Related]
5. [Personalized treatment of cancer: utopia or chance?]. Thiel E Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603 [No Abstract] [Full Text] [Related]
6. Genomic medicines for oncology: early lessons. Simons JW J Med Assoc Ga; 2003; 92(1):35-8. PubMed ID: 12743904 [No Abstract] [Full Text] [Related]
7. Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Garcia-Echeverria C; Sellers WR Oncogene; 2008 Sep; 27(41):5511-26. PubMed ID: 18794885 [TBL] [Abstract][Full Text] [Related]
8. The second wave in kinase cancer drugs. Garber K Nat Biotechnol; 2006 Feb; 24(2):127-30. PubMed ID: 16465146 [No Abstract] [Full Text] [Related]
9. A new probe for targeting drug delivery system. Yu Z; Wang B; Sui J; Feng Y; Zheng C Med Hypotheses; 2009 Jan; 72(1):43-4. PubMed ID: 18829175 [TBL] [Abstract][Full Text] [Related]
15. Active targeting schemes for nanoparticle systems in cancer therapeutics. Byrne JD; Betancourt T; Brannon-Peppas L Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489 [TBL] [Abstract][Full Text] [Related]
16. Combat against cancer with science and medicine. Chow LW; Toi M Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S3-4. PubMed ID: 20374027 [No Abstract] [Full Text] [Related]
17. Tumour-targeted drug and gene delivery: principles and concepts. Cassidy J; Schätzlein AG Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893 [TBL] [Abstract][Full Text] [Related]
18. Towards the small and the beautiful: smart targeting and smart technologies for novel cancer treatments. Loizidou M Curr Opin Pharmacol; 2012 Aug; 12(4):389-91. PubMed ID: 22770810 [No Abstract] [Full Text] [Related]
19. Synthesis and NMR characterization of hydroxyurea and mesylglycol glycoconjugates as drug candidates for targeted cancer chemotherapy. Sorg BL; Hull WE; Kliem HC; Mier W; Wiessler M Carbohydr Res; 2005 Feb; 340(2):181-9. PubMed ID: 15639238 [TBL] [Abstract][Full Text] [Related]
20. New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering. Gopin A; Rader C; Shabat D Bioorg Med Chem; 2004 Apr; 12(8):1853-8. PubMed ID: 15051054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]